Both in Blank Checks
TRG Latin America Acquisitions vs Drugs Made In America Acquisition
| Metric | TRGS | DMAA |
|---|---|---|
| Price | $9.97 | $10.89 |
| Market cap | $259.4M | $264.4M |
| Today | −0.20% | 0.00% |
| 1 month | — | +0.4% |
| 6 months | — | +2.7% |
| Year to date | — | +5.0% |
| 1 year | — | — |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | — | -$329.7K |
| Dividend yield | — | — |
| Volatility (60d) | — | 1.8% |
| Short % of float | 0.0% | 0.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).